Highlights:
- Quarterly Loss and Earnings Miss: Smith Micro Software (NASDAQ:SMSI) reported a quarterly loss of $0.38 per share, missing the Zacks Consensus Estimate of $0.35. This loss compares to $0.08 per share from the previous year, adjusted for non-recurring items, and represents an earnings surprise of -8.57%.
- Revenue Decline: The company reported revenues of $5.14 million for the quarter ended June 2024, which is a decrease from $10.34 million a year ago and missed the Zacks Consensus Estimate by 4.82%. Smith Micro has surpassed consensus revenue estimates only once in the past four quarters.
- Stock Performance and Future Outlook: Smith Micro Software shares have declined approximately 62.9% year-to-date, compared to the S&P 500's gain of 15.8%. The company's earnings outlook and estimate revisions trend are mixed, leading to a Zacks Rank #3 (Hold), indicating the stock is expected to perform in line with the market in the near future.
- Industry Context and Upcoming Competitor Earnings: The Zacks Industry Rank for Computer - Software is in the bottom 39%, with the top 50% of industries outperforming the bottom 50% by more than 2 to 1. Another industry stock, OptimizeRx Corp. (NASDAQ:OPRX), is expected to report a quarterly loss of $0.07 per share on August 8, with revenues projected to increase by 48.1% from the year-ago quarter.
Smith Micro Software, Inc. (NASDAQ:SMSI) reported a quarterly loss of $0.38 per share, missing the Zacks Consensus Estimate of a $0.35 loss. This compares to a $0.08 loss per share a year ago. These figures are adjusted for non-recurring items.
This earnings report represents a surprise of -8.57%. In the previous quarter, the company was expected to post a loss of $0.24 per share but reported a loss of $0.45, a surprise of -87.50%. Over the last four quarters, Smith Micro Software has surpassed consensus EPS estimates only once.
Smith Micro Software, part of the Zacks Computer - Software industry, reported revenues of $5.14 million for the quarter ended June 2024, missing the Zacks Consensus Estimate by 4.82%. This compares to year-ago revenues of $10.34 million. The company has exceeded consensus revenue estimates only once in the past four quarters.
The stock's immediate price movement will depend on management's commentary during the earnings call. Smith Micro Software shares have declined approximately 62.9% since the beginning of the year, compared to the S&P 500's gain of 15.8%.
What’s Next for Smith Micro Software?
While Smith Micro Software has underperformed the market this year, investors are left wondering about the stock’s future.
One reliable measure to address this is the company's earnings outlook, including current consensus earnings expectations for the upcoming quarters and how these expectations have changed recently. Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions themselves or rely on a rating tool like the Zacks Rank, which has a strong track record of harnessing the power of earnings estimate revisions.
Ahead of this earnings release, the estimate revisions trend for Smith Micro Software was mixed. The company's current status translates into a Zacks Rank #3 (Hold), indicating that the shares are expected to perform in line with the market in the near future.
The current consensus EPS estimate for the coming quarter is -$0.22 on $5.9 million in revenues, and -$1.15 on $24.7 million in revenues for the current fiscal year. The outlook for the industry can significantly impact the stock’s performance. The Zacks Industry Rank for Computer - Software is currently in the bottom 39% of over 250 industries, with the top 50% outperforming the bottom 50% by more than 2 to 1.
Upcoming Earnings in the Same Industry: OptimizeRx Corp. (OPRX)
Another stock in the same industry, OptimizeRx Corp. (NASDAQ:OPRX), is set to report results for the quarter ended June 2024 on August 8. OptimizeRx is expected to post a quarterly loss of $0.07 per share, representing a year-over-year change of -600%. The consensus EPS estimate for the quarter has been revised 32.1% lower over the last 30 days.
OptimizeRx Corp.'s revenues are expected to be $20.47 million, up 48.1% from the year-ago quarter.